Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00631566 · ClinicalTrials.gov registry record · NA
Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
A NA study, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Completed
- Registry status
- NA
- Development phase
- 550
- Enrollment target
NCT00631566 is a NA study that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 550 participants.
The verdict
NCT00631566, a NA study, has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 550 participants
- Enrollment target
Study Summary
This study will prospectively evaluate the prevalence and incidence (over a two year period) of MRSA colonization and infection among HIV-infected military beneficiaries to determine predictors for the development of MRSA colonization and infection. This study will also investigate the utility of decolonization procedures for clearance of MRSA carriage and prevention of MRSA infections. Finally, the molecular characteristics and the antimicrobial sensitivities of isolates in this population will be determined.
Interventions
- DRUG Placebo
- DRUG Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2007-05 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00631566
The ClinicalTrials.gov registry entry for NCT00631566 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00631566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00631566 about?
NCT00631566 is a clinical study titled "Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons". This study will prospectively evaluate the prevalence and incidence (over a two year period) of MRSA colonization and infection among HIV-infected military beneficiaries to determine predictors for the development of MRSA colonization and infection. This study will also investigate the utility of de...
What is the current status of trial NCT00631566?
This trial is currently completed. It is a NA study. The enrollment target is 550 participants. The study started on 2007-05. Estimated completion is 2017-10.
What interventions are being tested in trial NCT00631566?
The interventions under investigation include: Placebo (DRUG), Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3% (DRUG).
Who is sponsoring clinical trial NCT00631566?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.